You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic colorectal cancer (mCRC)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in United States (Rivoceranib, Trifluridine/Tipiracil)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Sarasota, Florida
  • +3 more
May 18, 2022

First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

Completed
  • BRAF V600E Mutation Positive
  • Metastatic Colorectal Cancer
  • Non Interventional study
  • St. Veit/Glan, Austria
  • +33 more
Jan 20, 2023

Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)

Terminated
Has Results
  • Colorectal Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 10, 2022

Metastatic Colorectal Cancer. Real-World Data Analysis.

Completed
  • Metastatic Colorectal Cancer
    • Istanbul, Turkey
      Istanbul Medeniyet University Hospital
    Oct 25, 2021

    Advanced Metastatic Colorectal Cancer Trial in Hangzhou (Raltitrexed, Irinotecan, Bevacizumab)

    Recruiting
    • Advanced Metastatic Colorectal Cancer
    • Hangzhou, Zhejiang, China
      the Second Affiliated Hospital of Medical College of Zhejiang Un
    Dec 22, 2021

    Metastatic Colorectal Cancer Trial in Taoyuan (TSB-9-W1)

    Completed
    • Metastatic Colorectal Cancer
    • Taoyuan, Taiwan
      Chang Gung Medical Foundation
    Mar 21, 2022

    Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Sep 24, 2023

    Fruquintinib in the Cross-line Treatment of Refractory mCRC

    Recruiting
    • Fruquintinib
    • Metastatic Colorectal Cancer
    • Wuhan, Hubei, China
    • +2 more
    Oct 23, 2023

    Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

    Completed
    • Metastatic Colorectal Adenocarcinoma
    • Changsha, Hunan, China
      Hunan Cancer hospital
    Sep 2, 2023

    Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • mCRC
    • Tislelizumab & Fruquintinib
    • Guangzhou, Guangdong, China
    • +1 more
    Jan 25, 2023

    Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece

    Completed
    • Metastatic Colorectal Cancer
    • Heraklion, Crete, Greece
    • +7 more
    Mar 4, 2022

    Regorafenib in Taiwan Metastatic Colorectal Cancer Patients

    Completed
    • Metastatic Colorectal Cancer
    • Taipei, Taiwan
      Taipei Veterans General Hospital
    Jul 21, 2021

    Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

    Completed
    • Metastatic Colorectal Cancer
    • Milan, MI, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Apr 1, 2022

    Metastatic Colorectal Cancer Trial in Madison (Panitumumab, Cetuximab, Irinotecan)

    Recruiting
    • Metastatic Colorectal Cancer
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Sep 13, 2022

    Metastatic Colorectal Cancer Trial in Denmark, Germany, Spain (FOLFIRI Protocol, SCO-101)

    Recruiting
    • Metastatic Colorectal Cancer
    • Aalborg, Denmark
    • +11 more
    Feb 28, 2022

    Metastatic Colorectal Cancer Trial in Wuhan (SBRT, Fruquintinib, Cadonilimab)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • SBRT, Fruquintinib, Cadonilimab
    • Wuhan, Hubei, China
      Cancer Center, Union Hospital, Tongji Medical College, Huazhong
    Feb 18, 2023

    Advanced or Metastatic Colorectal Cancer (mCRC) Trial (CA102N)

    Available
    • Advanced or Metastatic Colorectal Cancer (mCRC)
    • (no location specified)
    Mar 2, 2022

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston (CXCR1/2

    Recruiting
    • Metastatic Colon Adenocarcinoma
    • +20 more
    • CXCR1/2 Inhibitor SX-682
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 17, 2022

    Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

    Completed
    • Metastatic Colorectal Cancer
    • RAS Wild Type
    • Napoli, Italy
      Università della Campania Luigi Vanvitelli
    May 4, 2022

    Advanced or Metastatic Solid Tumors, Advanced or Metastatic Colorectal Cancer (mCRC) Trial in Gilbert, Aurora, Houston (CA102N,

    Enrolling by invitation
    • Advanced or Metastatic Solid Tumors
    • Advanced or Metastatic Colorectal Cancer (mCRC)
    • Gilbert, Arizona
    • +2 more
    Mar 2, 2022

    Metastatic Colorectal Cancer Trial (Niraparib)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • (no location specified)
    Jun 7, 2022

    Metastatic Colorectal Cancer Trial in Wuhan (SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab)

    Recruiting
    • Metastatic Colorectal Cancer
    • SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab
    • Wuhan, Hubei, China
      Xianglin Yuan
    Jun 24, 2022

    NSCLC, Metastatic Colorectal Carcinoma, Refractory Melanoma Trial in Pittsburgh (Pixatimod, Nivolumab, Cyclophosphamide (low

    Recruiting
    • NSCLC
    • +2 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Mar 28, 2022

    Metastatic Colorectal Cancer Trial in Baltimore (CY, GVAX, SGI-110)

    Completed
    • Metastatic Colorectal Cancer
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Mar 26, 2021

    Metastatic Colorectal Cancer Trial in France (Nexavar (Sorafenib) and irinotecan (Campto))

    Completed
    • Metastatic Colorectal Cancer
    • Nexavar (Sorafenib) and irinotecan (Campto)
    • Lille, France
    • +4 more
    Jun 17, 2021